Edgewise Therapeutics, Inc. (EWTX)

SEC filing

Edgewise Therapeutics, Inc.

EWTX · CIK 1710072

4/A · Aug 17, 2026 · Director, Chief Scientific Officer Russell Alan J was granted 65K Stock Option (Right to Buy)

4/A

Director, Chief Scientific Officer Russell Alan J was granted 65K Stock Option (Right to Buy)

PRIMARY DOCUMENT

xslF345X06/primarydocument.xmlSEC.gov

Graphics and non-inline formats (not embedded below).